Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Itcanbeon May 14, 2015 10:05pm
292 Views
Post# 23731065

RE:RE:RE:RE:RE:RE:RE:RE:Fair market value...

RE:RE:RE:RE:RE:RE:RE:RE:Fair market value...
Yeah you're right, terrible stock, no value, trading on puffy air, investors ought to consider the possibility of shorting it, don't you think?

It's a free market, investors can short it......... if they want to lose their shirt that is.

I would never dare shorting this stock at these prices unless I wanted to lose money.

Knight is now trading pretty much at the value of the cash they have in the bank.

So at the moment there is zero premium being given for its peerless management.

Or anything else.

Which is beyond ridiculous, in my opinion.

To me, this stock is so undervalued now it blows my mind.

Do some DD before you short or if you are considering shorting this stock.

And if you're short and aren't covering at these ridiculously low beaten down levels then you will probably be covering your shorts at much higher prices.

All just my opinion and I could very well be wrong. But I don't think I am.

GLTA longs
Bullboard Posts